A 2025 meta-analysis of three trials (878 participants) confirmed retatrutide achieved significantly greater weight reduction than placebo (mean difference approximately 14% of body weight) with no significant increase in overall adverse events [6][7]
In terms of safety and tolerability, the adverse events were primarily mild to moderate gastrointestinal reactions, with no reports of severe hypoglycemia or death
They offer a multifaceted approach to treatment, providing blood sugar control, weight management, and a suite of additional health benefits that extend well beyond glycemic efficacy
Engagement quartiles compare the frequency of Noom app opens (capped at 20 app opens per day) among users who weighed in within the specified measurement week
If you're in Branson considering your options, know that with Klinic, you'll receive medications backed by robust clinical data
Based on several pivotal trials in T2DM, the NKF KDOQI guidelines recommend intensive glycemic control (HbA1c 53 mmol/mol)[7%] to prevent or delay the progression of albuminuria and other macro and microvascular complications